Interestingly, high IGFBP7 serum levels have been linked to several factors that influence breast cancer risk, such as insulin resistance, obesity and increased risk of metabolic syndrome (5,6), which may increase the risk of type 2 diabetes mellitus. This evidence concerns the gene IGFBP7 and breast carcinoma.